| Pharmaceutical active ingredients: |
| Memantine Hydrochloride |
| Available forms, composition and doses of Namenda: |
| Solution; Oral; Memantine Hydrochloride 2 mg / mlTablets; Oral; Memantine Hydrochloride 10 mgTablets; Oral; Memantine Hydrochloride 15 mgTablets; Oral; Memantine Hydrochloride 20 mgTablets; Oral; Memantine Hydrochloride 5 mg |
| Namenda medical category: |
| Human:Antiparkinsonian drugsCentral nervous system agentsNeurodegenerative disease drugs |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N06DX01 - Memantine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Forest Laboratories |
| Related documents and information about Namenda: |
| Namenda prescribing information (PDF)Namenda XR prescribing information (PDF) |